Publication | Closed Access

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

Therapeutic Drug MonitoringMedicineMetronomic TherapyPharmacologySequential Dose-escalation StudyIntravenous Tlc388PharmacotherapyOncologyRadiation OncologyPhase 1